iCAD Leadership in Breast Health AI Showcased at ECR 2025
iCAD is capitalizing on 20+ years of innovation in breast health AI. As the first to bring AI-powered DBT detection to market, iCAD continues to lead the way with wide-ranging AI solutions, cloud-enabled connectivity, and next generation algorithms that are transforming patient care and breast health for the future, including...
The Evolution of iCAD
iCAD traces its origins to 1984 — a year of tremendous technological advancements: Dell Computers was founded, Apple introduced the Macintosh, and Sony released the Discman as the first portable CD player.[i],[ii],[iii] This year of inspiring innovation was the same year that Howard Howtek launched Howtek Inc., a technology company...
iCAD Announced a Finalist for the 2018 Design Excellence Awards
In March of 2017, we announced that our deep learning based digital breast tomosynthesis (DBT) solution – PowerLook Tomo Detection – had received approval from the U.S. Food and Drug Administration (FDA). For those not familiar, PowerLook Tomo Detection is a first-of-its-kind, concurrent-read computer aided detection solution designed to assist...